Advances in Sodium Channel Modulation in Epilepsy Therapy: Focus on Eslicarbazepine, Lacosamide and Cenobamate. (PubMed, Biomedicines) - Aug 28, 2026 - " Recent advances in sodium channel modulation have expanded therapeutic options for focal epilepsy and support the development of more selective, mechanism-based ASM therapies. Eslicarbazepine acetate, lacosamide, and cenobamate demonstrate favorable efficacy and tolerability profiles and may improve seizure control in patients with drug-resistant epilepsy."
Journal • Review • Cardiovascular • CNS Disorders • Epilepsy • Fatigue • Heart Failure
|
|
Anna Pradiuch; Karolina Wojtunik-Kulesza; Monika Rudkowska; Olga Wronikowska-Denysiuk
|